Ledger.Open graph →
SEC Form D · Amendment · filed January 22, 2018

J2 Bio-Pharma, LLC

Offering
$800K
Sold
$345K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WYNCOTE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

James Harris · Wyncote, PAExec · DirectorJames Fares · Las Vegas, NVExec · DirectorPhilip Kay · Grand Cayman, Cayman IslandsExec · DirectorMeredith C. Cartwright · London, United KingdomExec · DirectorMelvin C. Yellin · GAINESVILLE, FLExec · DirectorDavid Fisher · Ankeny, IAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗